🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
0.8941
-0.1359 (-13.19%)
At close: Nov 19, 2026, 4:00 PM EST
0.8975
+0.0034 (0.38%)
After-hours: Nov 19, 2026, 7:51 PM EST

INmune Bio Revenue

In the year 2025, INmune Bio had annual revenue of $50.00K with 257.14% growth. That makes INmune Bio the 46,553rd largest company in the world by revenue and 6,946th in the United States.

Revenue (ttm)
$50.00K
Revenue Growth
+257.14%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
21
Market Cap
27.68M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202550.00K36.00K257.14%
Dec 31, 202414.00K-141.00K-90.97%
Dec 31, 2023155.00K-219.00K-58.56%
Dec 31, 2022374.00K193.00K106.63%
Dec 31, 2021181.00K170.00K1,545.45%
Dec 31, 202011.00K--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.